I never said anything along those lines my question was IF A PATIENT WAS RESPONDING WHILE ON BAVI COULD THE TREATMENTS CONTINUE AFTER THE TRIAL WAS OVER ? If so management would know those numbers and they could report them to shareholders IE like the guy that was still living years after the cotara treatment